Evidence map›Paper›PMID 35520205›Full record

ArticleRSC advances2019

Expanded graphene oxide fibers with high strength and increased elongation.

Ashok D Ugale, LinLin Chi, Min-Kyu Kim, Sudong Chae, Jae-Young Choi, Ji-Beom Yoo

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 12 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 3 countries.

Ashok D UgaleSungkyunkwan Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University Suwon 440-746 Republic of Korea jbyoo@skku.edu.ORCID https://orcid.org/0000-0002-6546-5031
LinLin ChiAdvanced Materials Science and Engineering, Sungkyunkwan University Suwon 440-746 Republic of Korea jy.choi@skku.edu.
Min-Kyu KimSungkyunkwan Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University Suwon 440-746 Republic of Korea jbyoo@skku.edu.
Sudong ChaeAdvanced Materials Science and Engineering, Sungkyunkwan University Suwon 440-746 Republic of Korea jy.choi@skku.edu.
Jae-Young ChoiAdvanced Materials Science and Engineering, Sungkyunkwan University Suwon 440-746 Republic of Korea jy.choi@skku.edu.ORCID https://orcid.org/0000-0003-1042-6171
Ji-Beom YooSungkyunkwan Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University Suwon 440-746 Republic of Korea jbyoo@skku.edu.ORCID https://orcid.org/0000-0002-3074-6685
Government of the Republic of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the role of chemically expanded graphite in the fabrication of high-performance graphene oxide fibers by wet spinning. X-ray diffraction peak showed that the interplanar distance of the expanded graphene oxide (EGO) fiber was more than that of graphene oxide (GO) fiber due to the expanded graphite. X-ray photon spectroscopy analysis revealed that EGO was more oxidized than GO. The hydrogen bonding network and secondary intermolecular interaction made the EGO aqueous solution more stable and crystalline, and it was able to be stretched in the coagulation bath. Morphological analysis showed the excellent alignment and compactness of EGO sheets in the fibers. The increased interplanar distance between the EGO sheets favored the edge-to-edge interaction more than the basal plane interaction within the fiber, thus resulting in high mechanical strength (492 MPa) and increased elongation (6.1%).

Identifiers

PMID35520205
PMCPMC9060574
OpenAlexW2913350686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.